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Recent studies show that stathmin/Op18 may be an
important physiological regulator of microtubule
dynamics; the activity of stathmin/Op18 is controlled by
the actions of several signalling pathways, allowing it to
play a central role in coordinating microtubule behaviour.
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The regulation of microtubule dynamics in eukaryotic
cells is essential for a multitude of processes, such as cell
movement, morphology, division and cytoplasmic
organisation [1]. Microtubules are dynamic polymers of αβ
tubulin dimers, the behaviour of which is determined by a
combination of the rates of growth, shrinkage, rescue
(change from a shrinking to a growing state) and
catastrophe (change from a growing to a shrinking state).
This probably involves the coordinated action of several
proteins, but few have been identified and their mode of
action is unclear [2]. The protein stathmin/Op18,
however, has recently emerged as a potentially crucial
regulator of microtubule dynamics.
Stathmin/Op18 — a brief history
Stathmin/Op18 is a 19 kDa cytoplasmic protein that has
been independently isolated by a number of investigators
in the past few years [3–5]. Various observations indicated
that stathmin/Op18 plays an important role in cell
regulation. The protein is well conserved and highly
expressed in proliferating cells and neurons. Its expression
level changes markedly during development, cellular dif-
ferentiation and tissue regeneration, and is elevated in
some neoplastic cells. Particularly notable are the diverse
phosphoforms of stathmin/Op18 which have been
observed, the result of phosphorylation on four serine
residues that is stimulated by a wide range of extracellular
effectors and during mitosis.
Stathmin/Op18 consists of a carboxy-terminal α-helical
domain and an amino-terminal ‘regulatory’ domain that
contains the four serine phosphorylation sites (residues 16,
25, 38 and 63) that account for all the phosphoforms
observed [3]. These sites are the targets of multiple
kinases regulated both during the cell cycle and by signal
transduction cascades. Ser25 is a target for mitogen-acti-
vated protein (MAP) kinase, and both Ser25 and Ser38 are
targets for phosphorylation by cyclin-dependent kinases
(Cdks). Ser16 and Ser63 can be phosphorylated by protein
kinase A (PKA), and Ser16 by the Ca2+/calmodulin-
dependent kinase-Gr (CaMK IV/Gr). There are almost
certainly additional unidentified kinases which phospho-
rylate stathmin/Op18.
Modulation of stathmin/Op18 levels by overexpression or
with anti-sense cDNAs results in a striking cell-cycle
block at the G2/M transition, suggesting an involvement
in cell-cycle progression [5]. The function of
stathmin/Op18 remained elusive, however, until the
protein was purified in a screen for factors that could
inhibit microtubule polymerisation [6]. This showed that,
in vitro, stathmin/Op18 interacts with unpolymerised
tubulin and destabilises microtubules, and conversely that
its depletion from Xenopus egg extracts increases micro-
tubule formation. These effects were attributed to an
increased microtubule catastrophe rate, and may underlie
the previously observed cell-cycle blockade by stath-
min/Op18. These observations were a major breakthrough
in stathmin/Op18 research, and rapid progress has since
been made which has shown that stathmin/Op18 is a phos-
phorylation-controlled general physiological regulator of
microtubule dynamics.
Phosphorylation and microtubule destabilisation
It is now well established that stathmin/Op18 inhibits micro-
tubule polymerisation and also depolymerises microtubules
in a dose-dependent fashion; importantly, this has been
demonstrated in living cells [7,8]. Furthermore, phosphory-
lation of stathmin/Op18 on all four sites completely blocks
its microtubule-destabilising effect [9]. Thus, unphosphory-
lated stathmin/Op18 promotes microtubule disassembly,
and this activity is turned off by phosphorylation.
Overexpression of mutant forms of stathmin/Op18 in
which the phosphorylation sites are replaced by alanines
causes a major G2/M block [4] and destabilises micro-
tubules [7,8]. Interestingly, wild-type stathmin/Op18 also
destabilises interphase microtubules, but the cells
progress apparently normally through the cell cycle. This
difference occurs because the elevated kinase levels that
occur during mitosis are enough to phosphorylate and
thereby inactivate the overexpressed wild-type protein,
whereas the alanine mutants cannot be phosphorylated
and are constitutively active [7]. Phosphorylation-
mediated down regulation of stathmin/Op18 activity is
thus required for progression through mitosis.
Experiments using in vitro phosphorylated stathmin/Op18
or mutated forms have shown that its regulation may be
quite complex [9] (see Table 1). It appears that Ser16 and
Ser63 make the greatest contribution to stathmin/Op18
inactivation, a single aspartic acid substitution at Ser63
being sufficient to block the microtubule depolymerisa-
tion effect in microinjected cells [8]. Phosphorylation of
both Ser16 and Ser63 has a greater effect on microtubule
stability in vitro than that of either site alone, suggesting
an element of cooperativity. In contrast, phosphorylation
of Ser25 and Ser38 has little effect on microtubules in
vitro. Indeed, overexpression of the Ala16/Ala63 mutant
has a strong destabilising effect on microtubules, despite
being efficiently phosphorylated at both Ser25 and Ser38
by mitotic kinases [9]. 
A clue to the function of Ser25 and Ser38 phosphorylation
comes from overexpression of Ala25/Ala38 mutant stath-
min/Op18, which gives a strong cell-cycle block, and
causes microtubule depolymerisation [7]. It turns out that,
in this mutant, Ser16 and Ser63 do not become phospho-
rylated, probably accounting for its effects, and indicating
a necessity for ordered phosphorylation in stathmin/Op18
inactivation. Thus, Ser16 and Ser63 regulate microtubule
destabilisation, and phosphorylation of Ser25/Ser38 is
required for Ser16/Ser63 phosphorylation, at least during
mitosis. All the sites can be phosphorylated efficiently in
vitro, so it may be in the tubulin-bound form that sequen-
tial phosphorylation is required for stathmin/Op18 inacti-
vation, Ser25 and/or Ser38 phosphorylation allowing
access to the other two sites.
Stathmin/Op18 interacts directly with αβ tubulin dimers
[6,9,10,11], and no interaction has been observed between
stathmin/Op18 and microtubules. A 217 kDa complex
consisting of two tubulin heterodimers per stathmin/Op18
molecule was observed [10,11], and the interaction
appears to occur primarily between stathmin/Op18 and α-
tubulin [9]. The region of stathmin/Op18 necessary for
microtubule interaction has not been determined, but
deletion of the amino-terminal 54 amino acids destroys its
ability to depolymerise microtubules [7].
Whether stathmin/Op18 is truly a microtubule catastrophe
factor, as originally proposed [6], is still not clear. Some
studies have found a correlation between stathmin/Op18
and catastrophe frequency [12,13], but others have not
[10]. Stathmin/Op18 could simply sequester αβ tubulin
dimers and thereby alter the equilibrium conditions to
favour depolymerisation of microtubules, small changes
being sufficient to cause a rapid microtubule depolymeri-
sation [11]. It is also possible that sequestration can itself
increase catastrophe frequency, or that a combination of
both mechanisms is used.
Forming the spindle
Microtubules become more dynamic during cell division,
reflecting breakdown of the interphase network and
mitotic spindle function. In this regard, it is interesting
that stathmin/Op18 causes spindle disassembly in vitro
[6,14] and that, in cells expressing alanine mutants of
stathmin/Op18, the spindle does not form or has abnor-
mally short arms [7,9]. The microtubule-destabilising
effect of these mutant proteins thus appears to prevent
proper spindle formation. Two recent studies using
Xenopus egg extracts support a role for stathmin/Op18 in
spindle formation [13,14]. Inhibition of protein phos-
phatase 2A (PP2A) by okadaic acid was found to cause
excessive spindle microtubule growth in extracts, which
correlated with a decreased catastrophe frequency and
could be rescued by the addition of a constitutively-active
stathmin/Op18 mutant [13]. The catastrophe frequency
also decreased on immunodepletion of stathmin/Op18
from the extracts, suggesting that stathmin/Op18 may be a
substrate of PP2A in microtubule regulation, mediating at
least some of its effects on microtubule stability [13].
Stathmin/Op18 is known to be highly phosphorylated in
mitosis, so it was surprising that its phosphorylation was at
a similar low level in both mitotic and interphase Xenopus
egg extracts [14]. However, the addition of increasing
amounts of mitotic chromatin to the mitotic extract caused
a dose-dependent increase in stathmin/Op18 phosphoryla-
tion. Mitotic chromatin thus contains an activity that can
render a mitotic extract capable of hyperphosphorylating
stathmin/Op18. Inhibition of PP2A in the mitotic extract
could mimic these effects, so mitotic chromatin may
contain a PP2A inhibitor or a PP2A-activated kinase that
subsequently phosphorylates stathmin/Op18. This is so
far unresolved, but further establishes a link between
stathmin/Op18 and PP2A. The identification of the com-
ponents involved in this process is eagerly awaited. 
It was also found that microtubule nucleation around
mitotic chromatin is inhibited by immunodepletion of
stathmin/Op18 from Xenopus egg extracts. This may reflect
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Table 1
Stathmin/Op18 phosphorylation effects on microtubule stability.
Microtubule
Sites phosphorylated destabilisation
16 25 38 63
– – – – + + + +
– P P – + + +
P – – – + +
– – – P + +
P P P – +
– P P P +/–
P – – P –
P P P P –
Stathmin/Op18 was phosphorylated in vitro on the sites marked, and
the effects on microtubule polymerisation were observed in an in vitro
assay (from [9]).
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a physiologically relevant mechanism for regulating the
preferential growth of microtubules around chromosomes
during spindle assembly [14]. The authors emphasise that,
in the system they used, other microtubule-interacting pro-
teins also contribute to spindle formation. As yet, the roles
these proteins play and how they cooperate with stath-
min/Op18 are not clear; however, they may be regulated in
a similar fashion.
Although studies on mitosis have provided important
information on stathmin/Op18 action, it is possible that it
has a somewhat passive role in the regulation of mitosis.
All that may be required is that the microtubule-destabil-
ising activity of stathmin/Op18 action is simply switched
off during mitosis. Indeed, stathmin/Op18 is known to be
highly phosphorylated during mitosis. Also, some prolifer-
ating cell types do not express stathmin/Op18, and a stath-
min/Op18-deficient knockout mouse develops normally
[15]. However, this may well be because other stathmin-
related or microtubule-interacting proteins compensate for
the absence of stathmin/Op18 in these mutant mice.
A general regulator of microtubules?
There is increasing evidence that stathmin/Op18 plays a
general role in microtubule regulation in interphase cells,
and it is well established that stathmin/Op18 is phosphory-
lated in response to diverse extracellular signals [3–5].
Overexpression of constitutively-active CaMK IV/Gr
causes stathmin/Op18 phosphorylation on Ser16 and a con-
comitant increase in microtubule mass in the cell [16], thus
linking stathmin/Op18 to calcium signalling. Similar results
were obtained with PKA, thereby linking stathmin/Op18
to cyclic AMP signals [17]. Further support comes from the
observation that stathmin/Op18 is essential for nerve-
growth-factor-induced differentiation of PC12 cells [18].
The evidence that stathmin/Op18 is a physiological regula-
tor of microtubule dynamics is quite compelling. However,
an in vivo interaction between stathmin/Op18 and tubulin
has not yet been reported, probably for technical reasons.
SCG10, a stathmin/Op18-related protein expressed in the
nervous system, co-purifies with tubulin from calf brain
and destabilises microtubules [19]. Further support for an
in vivo role of stathmin/Op18 comes from very recent data
showing that lowering stathmin/Op18 levels with an anti-
body leads to increased tubulin polymerisation, consistent
with the proposed function of stathmin/Op18 [13]. 
Microtubules are also regulated by other proteins [2],
which probably work together with stathmin/Op18 to give
an appropriate response. For example, in interphase much
stathmin/Op18 is unphosphorylated but the microtubule
network does not collapse, probably because of a counter-
balancing effect of microtubule-stabilising proteins.
Effects on microtubules may occur at specific sub-cellular
regions, and phosphospecific antibodies may be useful to
detect any local changes in phosphorylation. Finally,
microtubule- interacting drugs, such as taxol, are well-
known therapeutic agents. Drugs that can modulate the
stathmin/Op18–tubulin interaction may therefore be of
clinical importance. 
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